Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective was to assess the acceptability of a 4-week treatment of 4 new fixed-dose combinations of fenofibrate and metformin, in patients with type 2 diabetes and dyslipidemia.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| fenofibrate and metformin fixed combination (drug) | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Quotation by Visual Numeric Rating Scale before and after 4-week treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Assessment of safety by reporting of Adverse Events |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Global Clinical Director Solvay | Solvay Pharmaceuticals | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Site 24 | Anzin | France | ||||
| Site 23 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Bachant |
| France |
| Site 21 | Bauné | France |
| Site 32 | Bersée | France |
| Site 34 | Briollay | France |
| Site 27 | Denain | France |
| Site 28 | Denain | France |
| Site 5 | Le Temple-de-Bretagne | France |
| Site 29 | Nantes | France |
| Site 2 | Nantes | France |
| Site 8 | Nantes | France |
| Site 9 | Nantes | France |
| Site 1 | Nort-sur-Erdre | France |
| Site 13 | Parçay-les-Pins | France |
| Site 26 | Quarouble | France |
| Site 7 | Saint Aignan Le Grand | France |
| Site 30 | Saint-Amand | France |
| Site 10 | Saint-Étienne-de-Montluc | France |
| Site 4 | Saint-Herblain | France |
| Site 11 | Sautron | France |
| Site 17 | Segré | France |
| Site 33 | Thiant | France |
| Site 12 | Thouars | France |
| Site 25 | Vieux-Condé | France |
| Site 20 | Vihiers | France |
| ID | Term |
|---|---|
| D050171 | Dyslipidemias |
| D044882 | Glucose Metabolism Disorders |
| ID | Term |
|---|---|
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D011345 | Fenofibrate |
| D004364 | Pharmaceutical Preparations |
| ID | Term |
|---|---|
| D058607 | Fibric Acids |
| D058610 | Isobutyrates |
| D002087 | Butyrates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
| D010647 | Phenyl Ethers |
| D004987 | Ethers |
| D001577 | Benzophenones |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D010636 | Phenols |
| D007659 | Ketones |
Not provided
Not provided